Back to Agenda
Mergers & Acquisitions – The Multinational Pharma Quagmire
Session Chair(s)
Moin Don
Founder and CEO, PVCON Consulting, Lead: South Asia Chapter (ISoP),, International Society of Pharmacovigilance (ISoP), India
Mergers & Acquisitions (M&A) within pharma companies has become a regular phenomenon and needs deeper analysis to understand its dynamics. During M&A, it is not only the PV domain which needs critical attention from a management perspective but equally important are others functions such as Legal/Regulatory Affairs/ Safety Database/ Change in QPPV &PSMF, etc. This session shall explore encompassing all such challenges faced by pharma companies during M&A process.
Speaker(s)
Contributing Panelist
Managing Director, Sagittal Pharma Consulting Ltd, United Kingdom
Contributing Panelist
Sr. Manager, Regulatory Affairs, Pfizer Limited, India
Contributing Panelist
Senior Director, Solution Architect Leader, Business Development,, Qinecsa Solutions , United States
Contributing Panelist
Deputy General Manager, Product Safety and Risk Management, Viatris Laboratories Ltd, India
Contributing Panelist
Proprietor, GAURANG SHAH & ASSOCIATES, India
Have an account?